GRI Partner Receives Third Frontier Funding
Girindus America, one of seven partners comprising UC's new
Genome Research Institute (GRI),
has received more than $1.1 million from the State of Ohio's Third Frontier Action Fund. Governor Bob Taft presented Girindus with their check Thursday, Oct. 23 during a ceremony at the Girindus building on Reading Road.
This Third Frontier funding will support the creation of a biomedical process facility focused on oligoneucleotide (synthetic RNA and DNA) production. Oligoneucleotide production could be key in the formation of potential therapeutics in the future. GRI will provide the research capabilities needed to validate the use of these newly created therapeutics.
"Its important for Ohio to be involved in the initial stages of the development of new therapeutics which have the potential to one day treat or even possibly cure diseases," said David Millhorn, PhD, director of UC's GRI. "This interaction between academic and private sector provides the best economic opportunities for the State of Ohio."
UC's GRI is a laboratory complex located on Galbraith Road in Reading, Ohio, focused on the study of the biological and genetic causes of some of the world's most prevalent diseases including obesity, heart disease and cancer. Unique partnerships with Wright State University, Cincinnati Children's Hospital Medical Center, Meridian Bioscience, Girindus America, Procter & Gamble Pharmaceuticals, the Air Force Research Lab and Acero, will aid in the translation of scientific research to the commercialization of drugs and diagnostics.
To learn more about Girindus America, visit
. To read Governor Bob Taft's official announcement, visit
.
Tags
Related Stories
On-site training in Speech & Hearing Clinic sets UC’s programs apart
August 27, 2026
At the University of Cincinnati’s Speech & Hearing Clinic, Doctor of Audiology and Speech-Language Pathology graduate students gain real-world experience while providing free speech and hearing services to the community.
Funding expands UC research into weight gain side effects of bipolar medication
August 26, 2026
University of Cincinnati researchers have been approved for funding by the Patient-Centered Outcomes Research Institute (PCORI) to expand the implementation of healthy lifestyle interventions and metformin prescription to help manage weight gain in overweight or obese youth taking second-generation antipsychotic medications.
One in four NFL players had CTE at death
August 25, 2026
Forbes cites research on concussions and football helmets by the University of Cincinnati in a report that found one in four NFL players had brain damage at death.